Sung S. Kim
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
National quality assurance program using digital cytopathology: a 5-year digital transformation experience by the Korean Society for Cytopathology.
Journal: Journal of pathology and translational medicine
Published: May 27, 2025
Longitudinal kinetics of neutralizing antibodies against circulating SARS-CoV-2 variants and estimated level of group immunity of booster-vaccinated individuals during omicron-dominated COVID-19 outbreaks in the Republic of Korea, 2022.
Journal: Microbiology spectrum
Published: September 26, 2023
Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample.
Journal: Epidemiology and health
Published: March 03, 2023
Kaposiform hemangioendothelioma of skull base with dura invasion in a pediatric patient: a case report.
Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
Published: December 28, 2022
Time Course Evaluation of Enzyme-Linked Immunosorbent Assays Based on Cell-Free Recombinant Proteins for Detection of Antibodies against Middle East Respiratory Syndrome Coronavirus.
Journal: Microbiology spectrum
Published: November 23, 2022
Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study.
Journal: Vaccines
Published: November 14, 2022
Six-month longitudinal immune kinetics after mRNA-1273 vaccination: Correlation of peak antibody response with long-term, cross-reactive immunity.
Journal: Frontiers in immunology
Published: September 02, 2022
Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination.
Journal: The Journal of infection
Published: June 13, 2022
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.
Journal: Frontiers in cellular and infection microbiology
Published: May 19, 2022
Last Updated: 09/26/2026